Engineered l-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments
Open Access
- 1 December 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 10 (12) , 3527-3536
Abstract
Bacteria equipped with genetically encoded lactate biosensors are promising tools for biopharmaceutical production, diagnostics, and cellular therapies. However, many applications involve glucose-rich and anoxic environments, in which current whole-cell lactate biosensors show low performance. Here we engineer an optimized, synthetic lactate biosensor system by repurposing the natural LldPRD promoter regulated by the LldR transcriptional regulator. We removed glucose catabolite and anoxic repression by designing a hybrid promoter, containing LldR operators and tuned both regulator and reporter gene expressions to optimize biosensor signal-to-noise ratio. The resulting lactate biosensor, termed ALPaGA (A Lactate Promoter Operating in Glucose and Anoxia), can operate in glucose-rich, aerobic and anoxic conditions. We show that ALPaGA works reliably in the probiotic chassisEscherichia coliNissle 1917 and can detect endogenous l-lactate produced by 3D tumor spheroids with an improved dynamic range. In the future, the ALPaGA system could be used to monitor bioproduction processes and improve the specificity of engineered bacterial cancer therapies by restricting their activity to the lactate-rich microenvironment of solid tumors.Keywords
Funding Information
- Fondation Bettencourt Schueller
- Agence Nationale de la Recherche (ANR-10-INSB-05-01, ANR18CE330015)
- H2020 European Research Council (657579)
- INSERM Atip-Avenir program
This publication has 75 references indexed in Scilit:
- Recent advances in lactic acid production by microbial fermentation processesBiotechnology Advances, 2013
- The Bacterial Response Regulator ArcA Uses a Diverse Binding Site Architecture to Regulate Carbon Oxidation GloballyPLOS Genetics, 2013
- Metabolic Alterations During the Growth of Tumour SpheroidsCell Biochemistry and Biophysics, 2013
- Clinical use of lactate monitoring in critically ill patientsAnnals of Intensive Care, 2013
- Multivariate analysis of cell culture bioprocess data—Lactate consumption as process indicatorJournal of Biotechnology, 2012
- Explicit hypoxia targeting with tumor suppression by creating an “obligate” anaerobic Salmonella Typhimurium strainScientific Reports, 2012
- Measuring the activity of BioBrick promoters using an in vivo reference standardJournal of Biological Engineering, 2009
- The non-pathogenicEscherichia colistrain Nissle 1917 – features of a versatile probioticMicrobial Ecology in Health and Disease, 2009
- Dual Role of LldR in Regulation of the lldPRD Operon, Involved in l -Lactate Metabolism in Escherichia coliJournal of Bacteriology, 2008
- Engineering BioBrick vectors from BioBrick partsJournal of Biological Engineering, 2008